Studies Compare Various Treatments for COVID-19
MONDAY, Nov. 28, 2022 (HealthDay News) — Sotrovimab is effective compared with molnupiravir for patients at high risk for severe outcomes from COVID-19; however, there is no difference for angiotensin receptor blockers versus placebo for management o…
Learn MoreBenzodiazepines Tied to Drug Overdose in Young People With Sleep Disorders
MONDAY, Nov. 28, 2022 (HealthDay News) — Benzodiazepines are associated with an increased risk for drug overdose among young people versus alternative pharmacologic treatments for common sleep disorders, according to a study published online Nov. 22 …
Learn MoreACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus
MONDAY, Nov. 21, 2022 (HealthDay News) — For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published online Nov. 11 in Arthritis & Rheumatology to coincide with the annual meeting of the …
Learn MoreFDA Approves First Drug to Delay Onset of Type 1 Diabetes
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of stage 3 type 1 diabetes in adults and children 8 years and older who currently have stage 2 type 1 …
Learn MoreFDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration is warning consumers to be careful when buying prescription medication online. While some pharmacy websites operate legally and can offer convenience, privacy, and lower c…
Learn MoreACR: Holding Methotrexate for Just a Week After Flu Vaccine Works for RA Patients
FRIDAY, Nov. 18, 2022 (HealthDay News) — For patients with rheumatoid arthritis (RA), temporarily discontinuing methotrexate for one week is noninferior to discontinuation for two weeks after seasonal flu vaccination to induce an immediate and long-t…
Learn MoreACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
FRIDAY, Nov. 18, 2022 (HealthDay News) — Patients with systemic lupus erythematosus (SLE) who are treated with lower doses of hydroxychloroquine (HCQ) have an increased risk for hospitalizations for SLE flares, according to a study presented at the a…
Learn MoreBenefits of Dapagliflozin in Heart Failure Similar for Men, Women
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Dapagliflozin is similarly beneficial for women and men with heart failure, according to a study published online Nov. 7 in Circulation.Xiaowen Wang, M.D., from Harvard Medical School in Boston, and colleag…
Learn MoreUnos peligrosos mitos evitan que muchos adultos con alergias a los alimentos tengan un EpiPen
LUNES, 14 de noviembre de 2022 (HealthDay News) — Se sabe que un EpiPen salva vidas cuando alguien con una alergia grave a un alimento come algo que no puede tolerar.Sin embargo, el autoinyector se utiliza muy poco en Estados Unidos, según una nueva …
Learn MoreRecent Increase Seen in Pediatric Benzonatate Exposure
TUESDAY, Nov. 15, 2022 (HealthDay News) — Pediatric benzonatate prescription utilization has increased recently, as have cases involving intentional benzonatate exposure, according to a study published online Nov. 15 in Pediatrics.Ivone Kim, M.D., fr…
Learn More